Cepheid Receives FDA Clearance for Test for HAI-Associated Gene
- Thu, 1/7/10 - 12:18pm
- 0 Comments
- 942 reads
Cepheid Wednesday announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert vanA, the first rapid and accurate test released in the United States for vanA, the antimicrobial resistance gene most commonly associated with vancomycin-resistant enterococci — one of the more serious healthcare-associated infections (HAI).
Fox Business





